Investigation
Kewaunee Scientific Corporation (KEQU)
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Menu
Investigation
09/14/2021
Initial Lawsuit
09/14/2021
Lawsuit Progression
12/14/2021
This is a class action on behalf of persons and entities that purchased or otherwise acquired Boston Beer securities between April 22, 2021 and September 8, 2021, inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors:
(1) that Boston Beer’s hard seltzer sales were decelerating;
(2) that, as a result, Boston Beer was reasonably likely to incur inventory write-offs;
(3) that the Company was reasonably likely to incur shortfall fees payable to third party brewers;
(4) that, as a result of the foregoing, Boston Beer’s financial results would be adversely impacted; and
(5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.